Mangoceuticals, Inc. (MGRX)

Total Valuation

Mangoceuticals has a market cap or net worth of $28.79 million. The enterprise value is $28.45 million.

Market Cap	28.79M
Enterprise Value	28.45M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 15.32 million shares outstanding.

Shares Outstanding	15.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	46.89
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.57.

Current Ratio	2.67
Quick Ratio	n/a
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a

Financial Efficiency

Return on equity (ROE) is -669.00% and return on invested capital (ROIC) is -1,006.40%.

Return on Equity (ROE)	-669.00%
Return on Assets (ROA)	-389.50%
Return on Capital (ROIC)	-1,006.40%
Revenue Per Employee	n/a
Profits Per Employee	-$8,851
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	NaN
200-Day Moving Average	NaN
Average Volume (30 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	4,850
Operating Income	-1.99M
Pretax Income	-2.00M
Net Income	-17,701
EBITDA	-1.99M
EBIT	-1.99M
Earnings Per Share (EPS)	-$0.00

Balance Sheet

The company has $699,802 in cash and $352,865 in debt, giving a net cash position of $346,937 or $0.02 per share.

Cash & Cash Equivalents	699,802
Total Debt	352,865
Net Cash	346,937
Net Cash Per Share	$0.02
Equity / Book Value	614,030
Book Value Per Share	0.04
Working Capital	434,028

Cash Flow

In the last 12 months, operating cash flow was -$1.35 million and capital expenditures -$43,102, giving a free cash flow of -$1.39 million.

Operating Cash Flow	-1.35M
Capital Expenditures	-43,102
Free Cash Flow	-1.39M
FCF Per Share	-$0.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Earnings Yield	-0.06%
FCF Yield	-4.83%
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a